Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation

References

• Aparicio-Vergara M, Tencerova M, Morgantini C, Barreby E, Aouadi M. 2017. Isolation of Kupffer cells and hepatocytes from a single mouse liver. Methods Mol Biol. 1639:161–171.
   PubMedGoogle Scholar
• Chandrakar P, Parmar N, Descoteaux A, Kar S. 2020. Differential induction of SOCS isoforms by Leishmania donovani impairs macrophage-T cell cross-talk and host defense. J Immunol. 204(3):596–610.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhong Z, Tan HY, Guo W, Zhang C, Tan CW, Li S, Wang N, Feng Y. 2020. Uncovering the anticancer mechanisms of Chinese herbal medicine formulas: therapeutic alternatives for liver cancer. Front Pharmacol. 11:293.
   PubMed Web of Science ®Google Scholar
• Cheng MX, Cao D, Chen Y, Li JZ, Tu B, Gong JP. 2019. α-Ketoglutarate attenuates ischemia-reperfusion injury of liver graft in rats. Biomed Pharmacother. 111:1141–1146.
   PubMed Web of Science ®Google Scholar
• Ciesielska A, Matyjek M, Kwiatkowska K. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 78(4):1233–1261.
   PubMed Web of Science ®Google Scholar
• Drake J, Sultana R, Aksenova M, Calabrese V, Butterfield DA. 2003. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress. J Neurosci Res. 74(6):917–927.
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Naka T. 2010. SOCS1, a negative regulator of cytokine signals and TLR responses, in human liver diseases. Gastroenterol Res Pract. 2010:470468.
   PubMed Web of Science ®Google Scholar
• Huang DQ, El-Serag HB, Loomba R. 2021. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors, and prevention. Nat Rev Gastroenterol Hepatol. 18(4):223–238.
   PubMed Web of Science ®Google Scholar
• Ilangumaran S, Bobbala D, Ramanathan S. 2017. SOCS1: regulator of T cells in autoimmunity and cancer. Curr Top Microbiol Immunol. 410:159–189.
   PubMed Web of Science ®Google Scholar
• Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J, Luo Z. 2018. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 17(16):2001–2018.
   PubMed Web of Science ®Google Scholar
• Kazankov K, Jørgensen S, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D, Grønbæk H. 2019. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 16(3):145–159.
   PubMed Web of Science ®Google Scholar
• Li H, Zhou Y, Wang H, Zhang M, Qiu P, Zhang M, Zhang R, Zhao Q, Liu J. 2020. Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis. Front Immunol. 11:1169.
   PubMed Web of Science ®Google Scholar
• Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. 2019. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 4(5):389–398.
   PubMed Web of Science ®Google Scholar
• Li W, Yu J, Zhao J, Xiao X, Li W, Zang L, Yu J, Liu H, Niu X. 2021. Poria cocos polysaccharides reduces high-fat diet-induced arteriosclerosis in ApoE-/- mice by inhibiting inflammation. Phytother Res. 35(4):2220–2229.
   PubMed Web of Science ®Google Scholar
• Liang G, Zhang L, Jiang G, Chen X, Zong Y, Wang F. 2021. Effects and components of herb pair huanglian-banxia on diabetic gastroparesis by network pharmacology. Biomed Res Int. 2021:1–14.
   PubMed Web of Science ®Google Scholar
• Liau N, Laktyushin A, Lucet IS, Murphy JM, Yao S, Whitlock E, Callaghan K, Nicola NA, Kershaw NJ, Babon JJ. 2018. The molecular basis of JAK/STAT inhibition by SOCS1. Nat Commun. 9(1):1558.
   PubMedGoogle Scholar
• Liu S, Sun Y, Li J, Dong J, Bian Q. 2017. Preparation of herbal medicine: er-Xian decoction and Er-Xian-containing serum for in vivo and in vitro experiments. J Vis Exp. 123:55654.
   Google Scholar
• Liu X, Latkolik S, Atanasov AG, Kunert O, Pferschy-Wenzig EM, Heiss EH, Malainer C, Schinkovitz A, Kollroser M, Dirsch VM, et al. 2017. Bupleurum chinense roots: a bioactivity-guided approach toward saponin-type NF-κB inhibitors. Planta Med. 83:1242–1250.
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Liu XL, Zhao J, Shi YJ, Yan LN, Chen XF, Li XH, You HB, Xu FL, Gong JP. 2008. The effects of SOCS-1 on liver endotoxin tolerance development induced by a low dose of lipopolysaccharide are related to dampen NF-kappaB-mediated pathway. Dig Liver Dis. 40(7):568–577.
   PubMedGoogle Scholar
• Lyu Y, Chen X, Xia Q, Zhang S, Yao C. 2020. Network pharmacology-based study on the mechanism of Pinellia ternata in asthma treatment. Evid Based Complement Alternat Med. 2020:9732626.
   PubMedGoogle Scholar
• Mancuso C, Pani G, Calabrese V. 2006. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep. 11(5):207–213.
   PubMed Web of Science ®Google Scholar
• Mazhar K. 2019. The future of nonalcoholic fatty liver disease treatment. Med Clin North Am. 103(1):57–69.
   PubMed Web of Science ®Google Scholar
• Miyao M, Kotani H, Ishida T, Kawai C, Manabe S, Abiru H, Tamaki K. 2015. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest. 95(10):1130–1144.
   PubMed Web of Science ®Google Scholar
• Mohar I, Brempelis KJ, Murray SA, Ebrahimkhani MR, Crispe IN. 2015. Isolation of non-parenchymal cells from the mouse liver. Methods Mol Biol. 1325:3–17.
   PubMedGoogle Scholar
• Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, Ajamieh H, Adams L, Hamdorf JM, Teoh NC, et al. 2017. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. Clin Sci. 131(16):2145–2159.
   Web of Science ®Google Scholar
• Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt HHHW. 2022. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 43(2):136–150.
   PubMed Web of Science ®Google Scholar
• Oseini AM, Sanyal AJ. 2017. Therapies in non-alcoholic steatohepatitis (NASH). Liver Int. 37:97–103.
   PubMed Web of Science ®Google Scholar
• Peng M, Zhu X, Yang X, Wang J. 2017. Isolation and identification of primary hepatocytes from nonalcoholic fatty liver rats. Sichuan Med. 38:21–24. Chinese.
   Google Scholar
• Pfister D, Núñez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, Gupta R, Qiu M, Deczkowska A, Weiner A, et al. 2021. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 592(7854):450–456.
   PubMed Web of Science ®Google Scholar
• Son ES, Park JW, Kim SH, Park HR, Han W, Kwon OC, Nam JY, Jeong SH, Lee CS. 2020. Anti‑inflammatory activity of 3,5,6,7,3′,4′‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells. Mol Med Rep. 22(3):1985–1993.
   PubMedGoogle Scholar
• Sumida Y, Yoneda M. 2018. Current and future pharmacological therapies for NAFLD/NASH. J Gastroenterol. 53(3):362–376.
   PubMed Web of Science ®Google Scholar
• Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. 2012. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J Biol Chem. 287(48):40161–40172.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Liu Y, Xu J, Liu Y. 2021. Gut-liver axis: liver sinusoidal endothelial cells function as the hepatic barrier in colitis-induced liver injury. Front Cell Dev Biol. 9:702890.
   PubMed Web of Science ®Google Scholar
• Xiong X, Kuang H, Ansari S, Liu T, Gong J, Wang S, Zhao XY, Li JY, Guo C, Zhou L, et al. 2019. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell. 75(3):644–660.e5.
   PubMed Web of Science ®Google Scholar
• Yang J-M, Sun Y, Wang M, Zhang X-L, Zhang S-J, Gao Y-S, Chen L, Wu M-Y, Zhou L, Zhou Y-M, et al. 2019. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. WJG. 25(34):5105–5119.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. 2018. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 15(1):11–20.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. 2016. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1):73–84.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhu C, Wang X, Kim K, Bartolome A, Dongiovanni P, Yates KP, Valenti L, Carrer M, Sadowski T, et al. 2021. Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis. Sci Transl Med. 13:eabe1692.
   PubMed Web of Science ®Google Scholar
• Yuan D, Huang S, Berger E, Liu L, Gross N, Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, et al. 2017. Kupffer cell-derived TNF triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell. 31(6):771.e6–789.e6.
   Web of Science ®Google Scholar
• Zhang CH, Xiao Q, Sheng JQ, Liu TT, Cao YQ, Xue YN, Shi M, Cao Z, Zhou LF, Luo XQ, et al. 2020. Gegen Qinlian Decoction abates nonalcoholic steatohepatitis associated liver injuries via anti-oxidative stress and anti-inflammatory response involved inhibition of toll-like receptor 4 signaling pathways. Biomed Pharmacother. 126:110076.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu X, Zheng D, Yin Y, Peng M, Wang J. 2020. Effects of Qutan Huoxue formula on the SOCS1/TLR4 signaling pathway in NASH model mice. Evid Based Complement Alternat Med. 2020:1570918. 2020
   PubMed Web of Science ®Google Scholar
• Zheng D, Peng M, Zhu X, Wang J. 2019. Effects of Qutanhuoxue decoction on AQP7 and AQP9 expression in nonalcoholic fatty liver model rats. Evid Based Complement Alternat Med. 2019:5709626.
   PubMed Web of Science ®Google Scholar